May 6, 2026 · Form 4 insider transaction
Hawryluk P. Kent sold 607 shares of MBX Biosciences, Inc. at $29.54 per share, a transaction worth $17.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
The sales reported on this Form 4 represent shares of common stock sold by the Reporting Person to cover tax obligations in connection with the vesting of restricted stock units, pursuant to a mandatory sell-to-cover agreement between the Reporting Person and the Company.; The price reported in Column 4 is a weighted average price. These shares were sold on an aggregrate basis for all Company participants, at prices ranging from $29.23 to $29.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregrate number of shares sold at each separate price within the range set forth in this footnote.